In diffuse large B cell lymphoma (DLBCL), MTA3 associates with an oncogenic transcription repressor, BCL6 [28], which plays a significant role in the development of a significant proportion of DLBCL [29]. The gene discussed is MTA3; the disease is diffuse large B-cell lymphoma.